← Leaderboards
Eric W. Dieperink
Minneapolis Va Medical Center
$0
Attributed
$0
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2019–23$1$1$1$0$0
'19
'20
'21
'22
'23
Funding mix
By agency
VA$0 · 1
By mechanism
I01$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Agonist”
- Julie Ake · National Institute Of Allergy And Infectious Diseases$22,000,000
- Aaron Esser-Kahn · University Of Chicago$13,378,548
- Nikej Shah · Nirsum Laboratories, Inc.$12,506,430
- Xinhua Li · Nano Terra, Inc.$11,941,250
- James Dale Berry · Brigham And Women'S Hospital$9,298,517
- James N Campbell · Centrexion Therapeutics Corporation$8,662,635
Research focus
AgonistAddictive BehaviorAlcohol Abuse TherapyAlcohol ConsumptionAlcohol CravingAlanine TransaminaseAlcohol Use DisorderAspartate TransaminaseBehavioralBiologicalBiological MarkersBrain Natriuretic PeptideCardiovascular SystemAlcoholsClinical PracticeClinical ResearchClinical TrialsCocaineCocaine UseCocaine UsersCooperative StudyCountryCravingDiabetes Mellitus
Grant awards (5)
A Randomized Trial of Pioglitazone for the Treatment of Alcohol Use Disorder$0
I01 · FY2023 · VA · contact PI
A Randomized Trial of Pioglitazone for the Treatment of Alcohol Use Disorder$0
I01 · FY2022 · VA · contact PI
A Randomized Trial of Pioglitazone for the Treatment of Alcohol Use Disorder$0
I01 · FY2021 · VA · contact PI
A Randomized Trial of Pioglitazone for the Treatment of Alcohol Use Disorder$0
I01 · FY2020 · VA · contact PI
A Randomized Trial of Pioglitazone for the Treatment of Alcohol Use Disorder$0
I01 · FY2019 · VA · contact PI